[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342706-105":59,"doc-detail-342706-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","development-of-a-long-term-ex-vivo-patient-derived-explant-model-of-endometrial-cancer","Development of a long term, ex vivo, patient-derived explant model of endometrial cancer","","Incidence of endometrial cancer (EC) is increasing in developed countries, while standard hysterectomy is often unsuitable for younger patients and those with high body mass index. Limited non-surgical options and insufficient biologically relevant models constrain research on alternatives to surgery. This study develops a long-term patient-derived explant (PDE) model of early-stage EC and demonstrates its use for evaluating predictive biomarkers for levonorgestrel intra-uterine system (LNG-IUS).",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-of-a-long-term-ex-vivo-patient-derived-explant-model-of-endometrial-cancer/342706/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-of-a-long-term-ex-vivo-patient-derived-explant-model-of-endometrial-cancer/342706.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why was a new non-surgical research model needed for endometrial cancer?","Question",{"text":113,"@type":114},"Standard hysterectomy is often infeasible for younger patients and those with high BMI, and non-surgical options remain limited. The study also highlights a lack of biologically relevant preclinical models that mirror in vivo response.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was the patient-derived explant (PDE) model developed in this study?",{"text":118,"@type":114},"Fresh tumour specimens from early-stage endometrioid EC were cut into explants and cultured on media-soaked gelatin sponges for up to 21 days. After culture, explants were processed into formalin-fixed, paraffin-embedded (FFPE) blocks.",{"name":120,"@type":111,"acceptedAnswer":121},"What treatment and biomarker evaluation were performed using the PDE model?",{"text":122,"@type":114},"Explant cultures were treated with levonorgestrel (LNG). Tumour architecture was assessed using H&E and immunohistochemistry, and IHC was used to evaluate five candidate biomarkers related to LNG resistance.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342706,1790956844,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","PLOS ONE  \nOPEN ACCESS  \nCitation: van der Woude H, Phan K, Kenwright DN, Goossens L, Hally KE, Currie MJ, et al. (2024) Development of a long term, ex vivo, patientderived explant model of endometrial cancer. PLoSONE 19(4): e0301413 . [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0301413](journal.pone.0301413)  \nEditor: Syed M. Faisal, University of Michigan Medical School, UNITED STATES  \nReceived: September 24, 2023  \nAccepted: March 16, 2024  \nPublished: April 18, 2024  \nCopyright: © 2024 van der Woude et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting Information files, including the minimal data set.  \nFunding: CH received Health Research Council NZ Emerging Researcher 21/608 Maridulu Budyari Gumal Sydney Partnership for Health, Education, Research and Enterprise [SPHERE] Cancer Clinical Academic Group Senior Research Fellowship (Funded by Cancer Institute NSW Translational Cancer Research Capacity Building Grant, 2021/ CBG0003, G. Sharbeen), and NHMRC Ideas Grant  \nRESEARCH ARTICLE  \nDevelopment of a long term, ex vivo, patientderived explant model of endometrial cancer  \nHannah vanderWoude1, Khoi Phan1, Diane N. Kenwright2, Louise Goossens3†, Kathryn Elizabeth Hally4, Margaret Jane Currie5, John Kokkinos6, George Sharbeen6, Phoebe  \nA. Phillips6, Claire Elizabeth Henry1 *  \n1 Department of Obstetrics, Gynaecology and Women’s Health, University of Otago, Wellington, New Zealand, 2 Department of Pathology and Molecular Medicine, University of Otago, Wellington, New Zealand, 3 Medical Photography, Capital, Coast and Hutt Valley, Wellington, New Zealand, 4 Department of Surgery and Anaesthesia, University of Otago, Wellington, New Zealand, 5 Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand, 6 Pancreatic Cancer Translational Research Group, School of Biomedical Sciences, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia  \n† Deceased.  \n* [claire.henry@otago.ac.nz](claire.henry@otago.ac.nz)  \nAbstract  \nIncidence of endometrial cancer (EC) is rising in the developed world. The current standard of care, hysterectomy, is often infeasible for younger patients and those with high body mass index. There are limited non-surgical treatment options and a lack of biologically relevant research models to investigate novel alternatives to surgery for EC. The aim of the present study was to develop a long-term, patient-derived explant (PDE) model of earlystage EC and demonstrate its use for investigating predictive biomarkers for a current nonsurgical treatment option, the levonorgestrel intra-uterine system (LNG-IUS) . Fresh tumour specimens were obtained from patients with early-stage endometrioid EC. Tumours were cut into explants, cultured on media-soaked gelatin sponges for up to 21 days and treated with LNG. Formalin-fixed, paraffin embedded (FFPE) blocks were generated for each explant after 21 days in culture. Tumour architecture and integrity were assessed by haematoxylin and eosin (H&E) and immunohistochemistry (IHC) . IHC was additionally performed for the expression of five candidate biomarkers of LNG resistance. The developed ex vivo PDE model is capable of culturing explants from early-stage EC tumours long-term (21 Days) . This model can complement existing models and may serve as a tool to validate results obtained in higher-throughput in vitro studies. Our study provides the foundation to validate the extent to which EC PDEs reflect patient response in future research.  \nIntroduction  \nEndometrial cancer (EC) is the most common gynaecological malignancy in the developed world but remains significantly under-researched [ 1–3] . The incid","cbCaivWORUuOMn36","https://ap.wps.com/l/cbCaivWORUuOMn36","pdf",4540424,"English","# Abstract\n# Introduction\n# Materials and Methods\n## PDE model development\n## LNG treatment and biomarker assessment\n# Results\n# Discussion","[{\"question\":\"Why was a new non-surgical research model needed for endometrial cancer?\",\"answer\":\"Standard hysterectomy is often infeasible for younger patients and those with high BMI, and non-surgical options remain limited. The study also highlights a lack of biologically relevant preclinical models that mirror in vivo response.\"},{\"question\":\"How was the patient-derived explant (PDE) model developed in this study?\",\"answer\":\"Fresh tumour specimens from early-stage endometrioid EC were cut into explants and cultured on media-soaked gelatin sponges for up to 21 days. After culture, explants were processed into formalin-fixed, paraffin-embedded (FFPE) blocks.\"},{\"question\":\"What treatment and biomarker evaluation were performed using the PDE model?\",\"answer\":\"Explant cultures were treated with levonorgestrel (LNG). Tumour architecture was assessed using H\\u0026E and immunohistochemistry, and IHC was used to evaluate five candidate biomarkers related to LNG resistance.\"}]","Development of a long term, ex vivo, patient-derived explant model of endometrial cancer | PDF",1790047801,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46a2e8d93022eb0497b3534918cb3f13.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ca1540bed89b60e5813d0b6d7679ea4.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eec97983365dfdd23a9bbb01f2876978.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17d010b6bcd0884d8ba50536d9d77b86.webp",980,1268]